Interested in marijuana stocks? Indeed, this market is fast growing and ready for the picking. This is why more and more people are looking for the best cannabis stocks to invest in.
List of Cannabis Stock to Invest In
Akerna Corp (KERN)
Akerna is the product of a merger launched in 2019 by MTech Acquisition Corp, a cannabis company, and MJ Freeway, a technology company that creates regulatory compliance tech as well as Enterprise Resource Planning.
This is the first marijuana compliance tech business traded at NASDAQ and is also the first company listed at NASDAQ that’s headed by a woman. Akerna keeps cannabis businesses connected to their supplier in a more accountable and transparent manner.
Aphira Inc. (APHA)
Aphira Inc. is a Canadian medical cannabis producer that’s the first purely cannabis company that trades on the NYSE and is initially traded in November 2018. Before this, Aphira was included in the OTC market in the United States as well as the Toronto Stock Exchange. The NYSE listing was a big step for the company as it opens to more investors.
Arena Pharmaceuticals (ARNA)
Arena Pharmaceuticals is a San Diego biotech company with a dedicated manufacturing facility dedicated to medical cannabis. Other areas of its facility manufacturers non-cannabinoid medications.
The center of Arena’s biotech operations is R and D of Olorinab APD371. This drug is still under investigational research, classified as a full agonist that binds to the cannabinoid receptor 2. Olorinab is currently being tested for the treatment of visceral pain due to gastrointestinal conditions.
Aurora Cannabis Inc. (ACB)
Aurora Cannabis is known as one of the best cannabis stocks to invest in, as it is one of the biggest marijuana companies all over the world. Aurora has eight manufacturing facilities, five sales licenses with operations in more than 15 countries.
Just to describe how big and how profitable investing in Aurora Cannabis is, it has a funded production capability of more than 500,000 kilograms, and recently, it has acquired medical cannabis company MedReleaf through a merger that costs $2.5 billion!
Canopy Growth Corp (CGC)
Canopy Growth is known as the largest cannabis company by market capitalization. It is the largest when it comes to funded production capacity at more than 500,000 kilograms. This company is always on the lookout for expansion, and last year it has 800,000 square feet of growing space, but now it has grown to more than 4.3 million feet. Canopy Growth’s production platform is 5.6 million feet, with 75% licensed.
cbdMD Inc (YCBD)
When it comes to CBD products, cbdMD Inc. is the company you can trust. It manufactures tinctures, gummies, oils, topical CBD, and pet care products. It is one of the most widely recognized names and has become more popular as it has partnered with former UFC champ Quinton “Rampage” Jackson and pro golfer Bubba Watson.
Recently, cbdMD has changed to Level Brands, and LEVB changed to YCBD according to shareholders. This is the only US company that’s focused on CBD traded in a major stock exchange
Corbus Pharmaceuticals Holdings Inc. (CRBP)
Corbus Pharmaceuticals is a pharmaceutical company dedicated to Phase 3 clinical trials of new medications focused on inflammatory illnesses and fibrotic conditions of the endocannabinoid system.
Corbus is currently testing Lenabasum, an oral cannabinoid receptor 2 agonists that have shown positive results with the treatment of systemic lupus erythematosus, cystic fibrosis, and other types of illnesses. Aside from Lenabasum, it is also researching other medications that can help treat conditions of the endocannabinoid system.
Cronos Group Inc. (CRON)
Cronos Group was one of the first sole cannabis stocks to join a major US exchange. It is a Canadian cannabis company that focused on medical cannabis as well as recreational marijuana after weed was fully legalized in Canada.
Cronos is still enhancing its production facility, and in 2019, the company was able to grow more than 47,000 kilograms. Cronos also owns Original BC and Peace Naturals, companies licensed to cultivate and sell medical cannabis in BC and Ontario.
FSD Pharma Inc. (HUGE)
FSD Pharma is not the average biotech company as it is involved in the pipeline of compounds approved by the FDA. These compounds directly affect the endocannabinoid system, which can treat different conditions such as autoimmune disorders, central nervous system disorders, gastrointestinal conditions, musculoskeletal conditions, and skin disorders.
FSD Pharma has a subsidiary known as FV Pharma that has secured a license to cultivate cannabis in Cobourg, Ontario.
Greenlane Holdings, Inc. (GNLN)
Greenlane Holdings initially offered its stocks on April 18. This is a Florida-based business that has distributed more than 140 brands of smoking equipment, vaporizers, and accessories all over the world. You can also find Greenlane products from commercial establishments.
Greenlane does not manufacture cannabis products, but its affiliation with the industry is one of the reasons why it’s experiencing huge gains in the market. Their products are also marketed across licensed cultivators, dispensaries, and marijuana processors.
GW Pharmaceuticals PLC (GWPH)
One of the closest to being a pure-play marijuana company is GW. This company is dedicated to the development of marijuana-based medications, as shown in their first drug called Sativex.
Sativex is used for the treatment of signs of multiple sclerosis. In fact, Sativex was the first natural cannabis-derived medication approved by different countries, including the UK. Sativex was approved in 2010 in the UK. Meanwhile, Epidolex was the first cannabis medication for the treatment of epilepsy approved by the FDA. This was also from GW Pharmaceuticals.
HEXO Corp (HEXO)
Based in Gatineau, Quebec, HEXO is focused on adult-use products. HEXO is very popular for its innovative approach to cannabis products with packaging and product designs developed for young and hip users.
HEXO was initially Hydropothecary Corp., but it changed to HEXO in 2018 after it launched its HEXO brand of adult-use products. Meanwhile, its medical products arm has remained a Hydropothecary brand. In the same year, HEXO and brewery company Molson Coors Brewing Co. created a joint venture to manufacture non-alcoholic, cannabis drinks for Canadians.
Innovative Industrial Properties Inc. (IIPR)
Innovative Industrial Properties is a real estate investment trust company that manages portfolios of properties that are leased to medical marijuana companies in the United States. Just among its clients are PharmaCann in New York and Massachusetts, Holistic Industries in Maryland and Massachusetts, The Pharm in Arizona, Vireo Health in New York, Minnesota, and Pennsylvania; and The Pharm in Arizona.
Intec Pharma Ltd. (NTEC)
IntecPharma Ltd. is another biotech company that relies on According Pill tech to manufacture its therapeutics line. The company is busy in the clinical research and development of AP-cannabinoids. These are being tested for the treatment of different conditions such as cancer-related pain, opioid-related pain, and many others through the use of one or two major cannabinoids: THC and CBD.
NewAge is an online healthy products shop that has brands like Bucha Live Kombucha, Evian, Nestea, Illy Coffee, as well as Volvic. The company wants to influence consumers to live healthier, and it does its part by offering these products, including Noni+CBD.
Noni+CBD has obtained approval by the Japanese Ministry of Health and Japanese Narcotics Control Division as a therapeutic product for countless ailments. NewAge also comes with hemp-derived products like moisturizing creams, oils, and topical gels. It is a widely known brand all over the world, especially in New Zealand and Australia.
OrganiGram Holdings Inc. (OGI)
OrganiGram cultivates indoor-grown adult-use and medicinal cannabis in Canada. It is one of the widely distributed product in 10 provinces of the country. The company has recently bagged organic certification coming from Pro-Cert Organic Systems Ltd for its recreational use cannabis.
During Canada’s year of legalizing cannabis edibles, OrganiGram invested around $15 million in a fully-automated production line of cannabis-laced chocolates. This manufacturing upgrade has a capacity of 4 million kilograms of cannabis chocolates yearly.
Pyxus International Inc. (NYSE: PYX)
Pyxus was once called Alliance One International and was a tobacco growing company. When it started growing cannabis, it changed its name to Pyxus. The company’s subsidiary Canadian Cultivated Products, has purchased 75% of Island Garden and 80% of Goldleaf Pharmaceuticals in Canada. Canadian Cultivated Products was later rebranded and is now called FIGR Cannabis.
Goldleaf has received a growing license from Health Ca while Island Garden was also granted a license to retail marijuana. Island Garden has inked a deal with Prince Edward Island for more than 1,000 kilograms of cannabis products. Also, Korent, a Pyxys International Subsidiary, is now a major hemp producer and also manufactures hemp CBD oil as well as helps oil liquid used in electronic cigarettes.
Sundial Growers Inc. (SNDL)
Sundial Growers is an Alberta, Canada –based company popular for its unique variety of cannabis strains. It is the company behind cannabis brands according to what users expect from cannabis like Heal, Play, and Help. Heal are cannabis products that are used for their therapeutic relief while Help are those for supporting overall wellbeing and health. Play is a cannabis product used for spiritual and social events. You can find Sundial in two physical locations in Alberta and British Columbia.
Therapix Biosciences Ltd. (NASDAQ: TRPX)
Therapix Biosciences is from Israel and is deep into research on Dronabinol, an FDA-approved cannabis-based medication THX-110. This medication is seen as a treatment for the symptoms of Tourette’s syndrome as well as obstructive sleep apnea.
THX-130 is another drug tested for the treatment of mild cognitive conditions and the THX-150 for the treatment of infectious conditions.
Tilray Inc. (TLRY)
Tilray is a pure-play cannabis company, the first one to be listed on NASDAQ. It is said that right after listing, its stocks increased eight times in just a matter of two months. Tilray was founded in 2013, and just three years, it was the first medical cannabis cultivator in North America to be awarded certification for good manufacturing processes
Tilray will soon be equal with Aurora and Canopy Growth when it comes to production capacity. It will soon expand to more than 900,000 square feet of growing area to fully expand its production capabilities.
22nd Century Group, Inc. (NYSE: XXII)
The 22nd Century Group is a biotechnology firm known for its research in the tobacco industry, including its efforts in making tobacco smoking less dangerous. It has developed its low nicotine tobacco, its cigarette that looks and smells like regular tobacco but has 95% fewer amounts of nicotine.
It was in 2014 when 22nd Century Group started research with cannabis through Anandia Labs. It also has access to hemp varieties with absent THC and steep CBD levels. It was revealed by 22nd Century Group that its most valuable partnership is with AgBiotech company KeyGene. This company specializes in crop enhancement through molecular breeding.
Village Farms International, Inc. (VFF)
Village Farms International is a greenhouse grower that publicly trades in Canada. It cultivates and sells fresh cannabis grown in large greenhouses in British Columbia and Texas as well as from its partners in Mexico, Ontario, and British Columbia.
It has large ownership in Pure Sunfarms, which is another Canada-based marijuana growing company. Village Farms International also has plans to establish itself as a leader in the US hemp CBD market as it already has two joint ventures: Arkansas Valley Green and Gold Hemp LLC and Village Fields Hemp USA, LLC.
Zynerba Pharmaceuticals Inc. (ZYNE)
Zynerba Pharmaceuticals is a biotech company that’s making progress in the research and development of transdermal cannabinoid treatments. These treatments are for very rare and near-rare neuro-psychiatric illnesses. One of its medicinal cannabis candidates is known as ZYN002 CBD, developed for children and adolescents diagnosed with Fragile X syndrome. This is a genetic condition that leads to poor intellectual capabilities, poor behavior, and learning, and it’s single-gene cause autism. Other medications still under research are those for epilepsy in adults.
Furthermore, there are cannabis stocks to invest in from non-cannabis companies. If you plan to invest in cannabis stocks, take time to get to know each company. Understand the different trends in the stock market and always consult a broker for professional guidance. If you’re a beginner trader, invest time in learning the ropes before you dive right in.